Jasper Therapeutics, Inc.

NasdaqCM:JSPR Stock Report

Market Cap: US$81.3m

Jasper Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of JSPR?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders189,1701.18%
Hedge Funds1,494,4209.3%
VC/PE Firms3,428,98121.3%
Institutions10,950,41068.2%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 93.81% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
9.95%
Soleus Capital Management, L.P.
1,494,420US$8.1m11.2%0.54%
9.54%
Velan Capital Partners LP
1,433,828US$7.8m0%9.29%
7.1%
Abingworth LLP
1,066,189US$5.8m0%4.25%
6.18%
Qiming Weichuang Venture Capital Management (Shanghai) Company Limited
928,964US$5.0m0%0.56%
5.38%
BlackRock, Inc.
808,086US$4.4m1.01%no data
4.76%
Braidwell LP
714,658US$3.9m47.9%0.2%
4.72%
The Vanguard Group, Inc.
709,484US$3.8m2.17%no data
4.33%
Integral Health Asset Management, LLC
650,000US$3.5m85.7%0.33%
4.02%
Morgan Stanley, Investment Banking and Brokerage Investments
604,519US$3.3m6.97%no data
3.89%
Samsara BioCapital LLC
584,642US$3.2m0%0.53%
3.86%
Franklin Resources, Inc.
579,636US$3.1m0%no data
3.08%
Rock Springs Capital Management LP
463,088US$2.5m0.87%0.1%
2.98%
Kingdon Capital Management, L.L.C.
447,000US$2.4m-10.1%0.47%
2.82%
Citadel Advisors LLC
423,610US$2.3m199%no data
2.66%
Opaleye Management Inc.
400,000US$2.2m13.2%0.41%
2.59%
FMR LLC
388,523US$2.1m913%no data
2.33%
Boxer Capital Management, LLC
350,000US$1.9m0%0.18%
2.15%
Great Point Partners, LLC
322,380US$1.7m0%0.99%
1.91%
Bank of America Corporation, Asset Management Arm
287,204US$1.6m-11.9%no data
1.72%
Geode Capital Management, LLC
257,687US$1.4m0.11%no data
1.65%
Russell Investment Management, LLC
247,272US$1.3m16.9%no data
1.64%
Woodline Partners LP
245,676US$1.3m-50.4%0.01%
1.63%
Avego Management, LLC
245,328US$1.3m0%no data
1.53%
State Street Global Advisors, Inc.
230,306US$1.2m7.18%no data
1.4%
Goldman Sachs Group, Investment Banking and Securities Investments
210,305US$1.1m0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/04 05:40
End of Day Share Price 2025/05/02 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Jasper Therapeutics, Inc. is covered by 14 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Matthew LuchiniBMO Capital Markets Equity Research
Etzer DaroutBMO Capital Markets Equity Research
Justin ZelinBTIG